Placebo for DCCR

DRUG2 trials

Sponsors

Soleno Therapeutics, Inc.

Conditions

Prader-Willi Syndrome

Phase 3

A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

CompletedNCT03440814

Soleno Therapeutics, Inc.Prader-Willi Syndrome

Start: 2018-05-09End: 2020-05-01Updated: 2023-09-21

Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period

CompletedNCT03714373

Soleno Therapeutics, Inc.Prader-Willi Syndrome

Start: 2018-10-01End: 2023-08-17Updated: 2024-04-19

Related Papers

Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study

Journal of Neurodevelopmental Disorders2024-04-265 citations